Literature DB >> 28325598

Sudomotor dysfunction as a measure of small fiber neuropathy in type 1 diabetes.

Lynn Ang1, Mamta Jaiswal1, Brian Callaghan2, David Raffel3, Morton B Brown4, Rodica Pop-Busui5.   

Abstract

BACKGROUND: This study evaluated whether measuring the electrochemical skin conductance (ESC), as an indirect measure of sudomotor function, may be also a reliable surrogate for early cardiovascular autonomic neuropathy (CAN).
METHODS: Longitudinal study included 37 type 1 diabetes (T1D) subjects (mean age 38±13years, duration 15±7years, HbA1c 7.9±1.1%, no known complications at baseline), and 40 age-matched healthy control (HC) subjects. Mean hands ESC (ESChands) and feet (ESCfeet) were measured with the SUDOSCAN (Impeto Medical, France). CAN was assessed with heart rate variability (HRV) studies (ANSAR Inc., PA), cardiovascular autonomic reflex tests (deep-breathing, Valsalva, postural test), and positron emission tomography with sympathetic analogue [11C]meta-hydroxyephedrine. Associations between measures of CAN and ESC were estimated using Spearman correlations. Longitudinal changes were analyzed using paired t-test.
RESULTS: At baseline, there were no differences between T1D and HC in ESChands (69±14 vs. 69±13μS; P=0.84) or ESCfeet (82±8 vs. 78±9μS; P=0.12), while some indices of HRV and Valsalva ratio were significantly lower in T1D vs. HC. T1D subjects experienced a significant decline in both ESChands and ESCfeet at 12months (mean change -7.2±11.6µS, P=0.0006; -2.8±7.3µS, P=0.023 respectively). No significant correlations were consistently found between ESC and measures of CAN at baseline or at 12months.
CONCLUSION: Comparing patients with T1D to controls, no differences in ESC were observed at baseline. The associations between ESC and established measures of CAN were inconsistent, which does not support ESC as a reliable surrogate for CAN. While both hands and feet ESC declined over time, the significance of this finding is unclear and warrants further reliability testing.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular autonomic neuropathy; Diabetic neuropathy; Sudomotor function; Type 1 diabetes

Mesh:

Year:  2017        PMID: 28325598      PMCID: PMC5476486          DOI: 10.1016/j.autneu.2017.03.001

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  29 in total

Review 1.  Assessment of cardiac sympathetic nerve integrity with positron emission tomography.

Authors:  D M Raffel; D M Wieland
Journal:  Nucl Med Biol       Date:  2001-07       Impact factor: 2.408

2.  Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.

Authors:  D Ziegler; G Laux; K Dannehl; M Spüler; H Mühlen; P Mayer; F A Gries
Journal:  Diabet Med       Date:  1992-03       Impact factor: 4.359

3.  Sudomotor function assessment as a screening tool for microvascular complications in type 2 diabetes.

Authors:  V G Eranki; R Santosh; K Rajitha; A Pillai; P Sowmya; J Dupin; J H Calvet
Journal:  Diabetes Res Clin Pract       Date:  2013-07-20       Impact factor: 5.602

4.  Normative Values for Electrochemical Skin Conductances and Impact of Ethnicity on Quantitative Assessment of Sudomotor Function.

Authors:  Aaron I Vinik; A Gordon Smith; J Robinson Singleton; Brian Callaghan; Barry I Freedman; Jaakko Tuomilehto; Lyse Bordier; Bernard Bauduceau; Frederic Roche
Journal:  Diabetes Technol Ther       Date:  2016-04-08       Impact factor: 6.118

5.  Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation.

Authors:  H Gin; R Baudoin; C H Raffaitin; V Rigalleau; C Gonzalez
Journal:  Diabetes Metab       Date:  2011-06-28       Impact factor: 6.041

Review 6.  Glucose control and diabetic neuropathy: lessons from recent large clinical trials.

Authors:  Lynn Ang; Mamta Jaiswal; Catherine Martin; Rodica Pop-Busui
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.

Authors:  Vincenza Spallone; Dan Ziegler; Roy Freeman; Luciano Bernardi; Simona Frontoni; Rodica Pop-Busui; Martin Stevens; Peter Kempler; Jannik Hilsted; Solomon Tesfaye; Phillip Low; Paul Valensi
Journal:  Diabetes Metab Res Rev       Date:  2011-10       Impact factor: 4.876

8.  The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy.

Authors:  A Gordon Smith; Margaret Lessard; Sandra Reyna; Mariana Doudova; J Robinson Singleton
Journal:  J Diabetes Complications       Date:  2014-03-06       Impact factor: 2.852

Review 9.  The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention.

Authors:  Aaron I Vinik; Marie-Laure Nevoret; Carolina Casellini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-11       Impact factor: 5.555

10.  SUDOSCAN: A Simple, Rapid, and Objective Method with Potential for Screening for Diabetic Peripheral Neuropathy.

Authors:  Dinesh Selvarajah; Tom Cash; Jennifer Davies; Adithya Sankar; Ganesh Rao; Marni Grieg; Shillo Pallai; Rajiv Gandhi; Iain D Wilkinson; Solomon Tesfaye
Journal:  PLoS One       Date:  2015-10-12       Impact factor: 3.240

View more
  9 in total

1.  Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?

Authors:  Sharika Rajan; Marta Campagnolo; Brian Callaghan; Christopher H Gibbons
Journal:  Clin Auton Res       Date:  2018-06-28       Impact factor: 4.435

2.  Electrochemical skin conductance to measure sudomotor function: the importance of not misinterpreting the evidence.

Authors:  Aaron I Vinik; Carolina M Casellini; Henri K Parson
Journal:  Clin Auton Res       Date:  2018-09-06       Impact factor: 4.435

Review 3.  Electrochemical skin conductance: a systematic review.

Authors:  Peter Novak
Journal:  Clin Auton Res       Date:  2017-09-26       Impact factor: 4.435

4.  Variability of electrochemical skin conductance for screening diabetes mellitus.

Authors:  Soochan Kim; Junghee Cho; Boncho Ku; Minho Jun; Gahye Kim; Horyong Yoo; Sangsoo Park; Jaeuk U Kim
Journal:  Biomed Eng Lett       Date:  2019-04-24

Review 5.  Diabetes Distal Peripheral Neuropathy: Subtypes and Diagnostic and Screening Technologies.

Authors:  Kelley Newlin Lew; Tracey Arnold; Catherine Cantelmo; Francky Jacque; Hugo Posada-Quintero; Pooja Luthra; Ki H Chon
Journal:  J Diabetes Sci Technol       Date:  2022-01-07

Review 6.  The Potential of Current Noninvasive Wearable Technology for the Monitoring of Physiological Signals in the Management of Type 1 Diabetes: Literature Survey.

Authors:  Elena Daskalaki; Anne Parkinson; Nicola Brew-Sam; Md Zakir Hossain; David O'Neal; Christopher J Nolan; Hanna Suominen
Journal:  J Med Internet Res       Date:  2022-04-08       Impact factor: 7.076

Review 7.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

8.  SUDOSCAN, an Innovative, Simple and Non-Invasive Medical Device for Assessing Sudomotor Function.

Authors:  Dana Elena Gavan; Alexandru Gavan; Cosmina Ioana Bondor; Bogdan Florea; Frank Lee Bowling; Georgeta Victoria Inceu; Liora Colobatiu
Journal:  Sensors (Basel)       Date:  2022-10-06       Impact factor: 3.847

9.  Association of serum stromal cell-derived factor 1 levels with EZSCAN score and its derived indicators in patients with type 2 diabetes.

Authors:  Wang-Shu Liu; Ling-Yan Hua; Su-Xiang Zhu; Feng Xu; Xue-Qin Wang; Chun-Feng Lu; Jian-Bin Su; Feng Qi
Journal:  Endocr Connect       Date:  2022-04-26       Impact factor: 3.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.